I. Chazova

发表

Features of the clinics and treatment of patients with obesity and hypertension (according to the National register of arterial hypertension).

E. Oshchepkova, N. Lazareva, I. Chazova, 2018, Terapevticheskii arkhiv.

The value of cardiovascular magnetic resonance in myocarditis with different clinical presentation.

I. Chazova, O. Stukalova, E. Gupalo, 2019, Terapevticheskii arkhiv.

Consensus on patients with hyperuricemia and high cardiovascular risk treatment

E. Oshchepkova, I. Chazova, J. V. Zhernakova, 2019, Systemic Hypertension.

Calcium channel blockers: more than 50 years on guard of health

I. Chazova, Y. Zhernakova, 2015 .

Vascular wall status and its link with perivascular adipose tissue and other fat depots in young patients with abdominal obesity

I. Chazova, M. Shariya, J. V. Zhernakova, 2019 .

EURASIAN CLINICAL GUIDELINES ON DIAGNOSIS AND TREATMENT OF PULMONARY HYPERTENSION

O. Barbarash, I. Chazova, O. Stukalova, 2020 .

Efficacy and safety of using a fixed-dose combination of azilsartan medoxomil and chlorthalidone in patients with diabetes mellitus

I. Chazova, J. V. Zhernakova, 2021 .

Real-life safety and effectiveness of amlodipine/valsartan combination in the treatment of hypertension

I. Chazova, A. Vigdorchik, N. Dongre, 2011, Advances in therapy.

The prevalence of renal dysfunction in arterial hypertension (in the framework of the ESSE-RF study)

S. Shalnova, A. Konradi, O. Rotar, 2015 .

[Epicardial adipose tissue as a marker of visceral obesity and its association with metabolic parameters and remodeling of the left chambers of the heart in young people with abdominal obesity].

E. Yarovaya, I. Chazova, N. Blinova, 2019, Terapevticheskii arkhiv.

Epicardial fat: a new cardiometabolic risk marker, a new therapeutic goal in obese patients

I. Chazova, N. Blinova, Y. Zhernakova, 2018, Systemic Hypertension.

Changes in the receptor activity of β2-adrenoreceptors of human T-lymphocytes under the effect of β2-agonists

I. Chazova, N. Mironova, S. Golitsyn, 2016, Molecular Biology.

May Measurement Month 2017 in Russia: hypertension treatment and control—Europe

N. Poulter, A. Konradi, O. Rotar, 2019, European heart journal supplements : journal of the European Society of Cardiology.

Isolated systolic arterial hypertension

I. Chazova, Г. Ратова, L. G. Ratova, 2018 .

[Cardiogenic shock in patients with acute coronary syndrome (data from Russian Federal Acute Coronary Syndrome Registry)].

I. Chazova, O. Sagaydak, E. Oschepkova, 2019, Terapevticheskii arkhiv.

[Optimization of specific therapy for pulmonary hypertension: the possibilities of riociguat].

I. Chazova, T. Martynyuk, S. Gorbachevsky, 2021, Terapevticheskii arkhiv.

Initial Riociguat Monotherapy and Transition from Sildenafil to Riociguat in Patients with Idiopathic Pulmonary Arterial Hypertension: Influence on Right Heart Remodeling and Right Ventricular–Pulmonary Arterial Coupling

I. Chazova, M. Saidova, T. Martynyuk, 2018, Lung.

The role of intervention methods of treatment of patients with resistant hypertension in contemporary cardiology

I. Chazova, O. Sagaydak, R. Agaeva, 2018 .

May Measurement Month 2018: a pragmatic global screening campaign to raise awareness of blood pressure by the International Society of Hypertension

P. López-Jaramillo, D. Prabhakaran, E. O’Brien, 2019, European heart journal.

Uncontrolled arterial hypertension: main causes, features of pathogenesis and approaches to treatment

I. Chazova, O. Sivakova, Anastasiia R. Denisova, 2021 .

Improved Hypertension Control with the Imidazoline Agonist Moxonidine in a Multinational Metabolic Syndrome Population: Principal Results of the MERSY Study

I. Chazova, M. Schlaich, 2013, International journal of hypertension.

Тhе patients оf high cardiovascular risk of healthy: unrecognized metabolic syndrome

E. Oshchepkova, I. Chazova, Y. Zhernakova, 2016 .

Obesity as a predictor for cardiovascular disease development: role of localized fat depot

I. Chazova, Y. Zhernakova, M. Azimova, 2018, Systemic Hypertension.

Efficacy and safety of azilsartan medoxomil in various doses in patients with metabolic disorders

N. Perepech, I. Chazova, J. V. Zhernakova, 2021, Systemic Hypertension.

An international multicenter observational non-interventional prospective study of the efficacy of azilsartan medoxomil in overweight or obese patients with arterial hypertension (CONSTANT)

I. Chazova, Y. Zhernakova, 2020, Current medical research and opinion.

The prevalence of abdominal obesity and the association with socioeconomic status in Regions of the Russian Federation, the results of the epidemiological study - ESSE-RF

S. Shalnova, S. Boytsov, E. Yarovaya, 2018, Terapevticheskii arkhiv.

The prevalence of abdominal obesity and the association with socioeconomic status in Regions of the Russian Federation, the results of the epidemiological study - ESSE-RF.

S. Shalnova, S. Boytsov, E. Yarovaya, 2018, Terapevticheskii arkhiv.

[On the way to achieve hypertension treatment goals: results of the open observational program AESCULAP (exforge--clinical safety and efficiency of using a double combination of antihypertensive drugs in patients with uncontrolled blood pressure)].

I. Chazova, T. Martynyuk, 2013, Terapevticheskii arkhiv.

[Pathology of primary pulmonary hypertension].

V. S. Zhdanov, I. Chazova, V. Mareev, 1993, Arkhiv patologii.

Quality of life in patients with idiopathic pulmonary hypertension: the first experience of trimetazidine

I. Chazova, T. Martynyuk, S. Nakonechnikov, 2017 .

Experts of RMSAH opinion: the fixed combination of azilsartan medoxomil and chlortalidone is broadening options of the combined therapyin patients with arterial hypertension

I. Chazova, Y. Karpov, Y. Zhernakova, 2015 .

The assessment of renal function during the therapy of arterial hypertension with azilsartan medoxomil in patients with obesity or overweight and concomitant metabolic disorders

I. Chazova, J. V. Zhernakova, V. Nevzorova, 2022 .

[The State of Vascular Bed, Parenchyma and Perfusion of Lungs in Chronic Thromboembolic Pulmonary Hypertension According to Data of Subtraction Pulmonary Angiography].

I. Chazova, T. Martynyuk, T. Veselova, 2018, Kardiologiia.

[Subtraction CT angiopulmonographic assessment of the vascular bed and lung perfusion in patients with chronic thromboembolic pulmonary hypertension: A pilot study].

I. Chazova, T. Martynyuk, T. Veselova, 2017, Terapevticheskii arkhiv.

EURASIAN ASSOCIATION OF CARDIOLOGY (EAC) GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION (2020)

R. Akchurin, I. Chazova, O. Stukalova, 2021, Eurasian heart journal.

[Clinical guidelines for the diagnosis and treatment of chronic thromboembolic pulmonary hypertension (Part 1)].

I. Chazova, T. Martynyuk, 2016, Terapevticheskii arkhiv.

Diuretics in combination antihypertensive therapy: focus on forecast

I. Chazova, T. Martyniuk, 2016 .

[Adherence and efficacy of long-term PAP therapy in patients with sleep-related breathing disorders associated with cardiac conduction disorders].

I. Chazova, S. Golitsyn, A. Pevzner, 2020, Terapevticheskii arkhiv.

Communication of subcutaneous, visceral, periaortic, epicardial fat and metabolic parameters with arterial stiffness in young people with abdominal obesity

E. Yarovaya, I. Chazova, M. Shariya, 2018, Systemic Hypertension.

Cognitive function and the emotional state of stroke patients on antihypertensive therapy

I. Chazova, V. Sinitsyn, D. Ustyuzhanin, 2007, Neuroscience and Behavioral Physiology.

Chronotherapy’s opportunities of a fixed combination of perindopril 10 mg/ indapamide 2.5 mg in patients with a lack of night reduction in blood pressure

I. Chazova, E. Elfimova, A. Aksenova, 2016 .

The influence of antyhypertensive therapy of valsartan and fixed combination with hydrochlorothiazide use on pulse-wave velocity and central arterial pressure in patients with arterial hypertension of 1-2 grades in international VICTORY clinical trial

Yu. I. Grinshtein, O. Rotar, I. Chazova, 2018, Systemic Hypertension.

[Social-demographic aspects of insomnia in the Russian population according to ESSE-RF study].

S. Shalnova, A. Konradi, O. Rotar, 2018, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova.

Severity of carbohydrate metabolism disturbances, arterial hypertension stage, and lipid profile in patients with metabolic syndrome

I. Chazova, Y. Zhernakova, S. Olimpieva, 2012 .

Sleep obstructive apnoea syndrome as an independent cardiovascular risk factor

I. Chazova, M. Bolotova, A. Litvin, 2022 .

Restenosis risk factors after coronary stenting in metabolic syn4 drome patients

Михаил Михайлович Данилов, I. Chazova, T. Gorgadze, 2018 .

Eurasian guidelines for the diagnosis and treatment of pulmonary hypertension associated with congenital heart defects in adults (2021)

I. Chazova, O. Stukalova, T. Martynyuk, 2022, Eurasian heart journal.

Continuous positive airway pressure (CPAP) therapy in patients with obstructive sleep apnea syndrome and arterial hypertension: expert opinion

I. Chazova, E. Elfimova, A. Litvin, 2018, Systemic Hypertension.

Radioligand method of assessment of human T-lymphocytes’ β-adrenoceptors activity

I. Chazova, Y. Skoblov, K. Zykov, 2015, Russian Journal of Bioorganic Chemistry.

The first results of an international clinical trial VICTORY: the efficacy and safety of antihypertensive valsartan monotherapy and the fixed combination of valsartan and hydrochlorothiazide using different dosage regimens in patients with 1–2 degree arterial hypertension

I. Chazova, T. Martyniuk, 2015 .

Guidelines on treatment of patients with arterial hypertension comorbid with metabolic disorders and diabetes mellitus type 2

O. Y. Sukhareva, M. Shestakova, I. Chazova, 2020 .

лечение ожирения больных с метаболическим синдромом Obesity pharmaceutical correction in metabolic syndrome patients

I. Chazova, V. Sergienko, V. Mychka, 2018 .

Diagnosis and treatment of arterial hypertension [Guidelines]

I. Chazova, Y. Zhernakova, 2019, Systemic Hypertension.

[Use of nebivolol in patients with idiopathic pulmonary hypertension: results of the pilot study].

I. Chazova, I. Konosova, T. Martyniuk, 2012, Terapevticheskii arkhiv.

Radiofrequency renal denervation with different device for treatment in patient with uncontrolled hypertension

I. Chazova, O. Sagaydak, Чазова Ирина Евгеньевна, 2018, Systemic Hypertension.

[Features of antihypertensive therapy and real-world prescription of selective imidazoline receptor agonists in Russia vs other countries: STRAIGHT study data analysis].

A. Schutte, A. Konradi, A. Konradi, 2021, Terapevticheskii arkhiv.

[Rehabilitation in patients with chronic thromboembolic pulmonary hypertension].

I. Chazova, O. Sagaydak, N. Danilov, 2022, Terapevticheskii arkhiv.

Balloon pulmonary angioplasty for patients with inoperable chronic thromboembolic pulmonary hypertension.

S. Boytsov, I. Chazova, O. Sagaydak, 2019, Terapevticheskii arkhiv.

[Primary pulmonary hypertension: activation of sympathico-adrenal system and free radical oxidation. Positive effects of carvedilol therapy].

T. Krasnikova, I. Chazova, V. Lankin, 2005, Terapevticheskii arkhiv.

AMBRISENTAN: THE POSSIBILITY OF THE TREATMENT FOR PULMONARY ARTERIAL HYPERTENSION WITH THE SELECTIVE BLOCKADE OF THE ENDOTHELIN SYSTEM

I. Chazova, S. Nakonechnikov, T. Martynuk, 2014, Eurasian heart journal.

Chronic kidney disease in outpatients with arterial hypertension: clinical characteristics and treatment efficacy (according to the national registry)

I. Chazova, E. Oschepkova, A. Orlovsky, 2022, Terapevticheskii arkhiv.

Clinical practice guidelines on the diagnosis and treatment of patients with arterial hypertension and chronic obstructive pulmonary disease

E. Oshchepkova, I. Chazova, J. V. Zhernakova, 2020 .

[Bosentan use in pulmonary arterial hypertension: Russian and foreign experience].

I. Chazova, T. Martynyuk, Z. Valieva, 2017, Terapevticheskii arkhiv.

[The incidence of cardiovascular and cerebrovascular complications in patients with uncontrolled hypertension].

I. Chazova, O. Sivakova, T. D. Solntseva, 2022, Terapevticheskii arkhiv.

Chronic thromboembolic pulmonary hypertension: modern view on the problem

I. Chazova, N. Danilov, Y. Matchin, 2019, Kardiologicheskii vestnik.

Interrelation of erectile dysfunction with obesity in patients with arterial hypertension.

I. Chazova, M. Shariya, S. Gamidov, 2018, Terapevticheskii arkhiv.

Antecubital vein access for balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension: safe new approach

I. Chazova, O. Sagaydak, N. Danilov, 2019, Russian Open Medical Journal.

The validation of the questionnaire for the early detection of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension

I. Chazova, S. Glukhova, Z. Valieva, 2016 .

[Characteristics of patients with chronic thromboembolic pulmonary hypertension according to the Russian National Registry].

I. Chazova, T. Martynyuk, Z. Valieva, 2021, Terapevticheskii arkhiv.

Expert Council resolution on pulmonary arterial hypertension (PAH) "Changing the paradigm of treating patients with pulmonary arterial hypertension".

I. Chazova, T. Martynyuk, 2019, Terapevticheskii arkhiv.

[Clinical guidelines for the diagnosis and treatment of chronic thromboembolic pulmonary hypertension (Part 2)].

I. Chazova, T. Martynyuk, 2016, Terapevticheskii arkhiv.

[Features of clinical, functional and hemodynamics profile, medical treatment and prognosis evaluation in patients with inoperable chronic thromboembolic pulmonary hypertension and idiopathic pulmonary arterial hypertension according to the Russian registry].

I. Chazova, T. Martynyuk, Z. Valieva, 2019, Terapevticheskii arkhiv.

Strategy of medical treatment of pulmonary arterial hypertension in the current international recommendations

I. Chazova, В МартынюкТ, Е ЧазоваИ, 2016 .

[Clinical guidelines for the diagnosis and treatment of pulmonary hypertension].

I. Chazova, S. Avdeev, I. Chazova, 2014, Terapevticheskii arkhiv.

[A clinical case of hemangioma of the face and tongue concurrent with severe obstructive sleep apnea syndrome complicated by cardiac arrhythmias and conduction disturbances].

I. Chazova, E. Butorova, E. Elfimova, 2016, Terapevticheskii arkhiv.

[Seх differences in treatment of acute coronary syndrome patients. Data from federal registry of acute coronary syndrome 2016-2019].

I. Chazova, O. Sagaydak, E. Oschepkova, 2022, Terapevticheskii arkhiv.

Phenotypic characteristics of patients with arterial hypertension and chronic obstructive pulmonary disease

I. Chazova, K. Zykov, O. Agapova, 2012 .

Pulmonary hypertension or cardiology aerobatics

I. Chazova, T. Martynyuk, N. Danilov, 2020 .

MANAGEMENT OF PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION IN THE PANDEMIC OF A NEW CORONAVIRUS INFECTION

I. Chazova, T. Martynyuk, A. V. Zorin, 2020 .

The state of the microcirculation of the skin in patients with pulmonary hypertension due to congenital heart defects

I. Chazova, A. Fedorovich, E. Dolgova, 2018, Regional blood circulation and microcirculation.

Features of cutaneous microcirculatory blood flow in patients with pulmonary hypertension of different etiology

I. Chazova, A. Fedorovich, A. Rogoza, 2016 .

[Possibilities of rational combination antihypertensive therapy: results of HEMERA international clinical trial].

I. Chazova, T. Martyniuk, 2013, Terapevticheskii arkhiv.

Clinical features of arterial hypertension in men and women (according to the National Registry of Arterial Hypertension).

I. Chazova, E. Oschepkova, A. Aksenova, 2019, Terapevticheskii arkhiv.

Eurasian guidelines for the prevention and treatment of cardiovascular diseases in patients with obesity (2022)

I. Zhirov, I. Chazova, A. Safiullina, 2022, Eurasian heart journal.

Direct renin inhibitor aliskiren in women with menopausal metabolic syndrome and arterial hypertension

I. Chazova, Y. Zhernakova, V. Mychka, 2011 .

[Antihypertensive therapy in men and women in real clinical practice according to the National register].

I. Chazova, A. Aksenova, E. V. Oshhepkova, 2019, Terapevticheskii arkhiv.

Diuretics in patients with metabolic disturbances

I. Chazova, V. Mychka, A. Myasnikov, 2018 .

[New opportunities of renal denervation].

I. Chazova, R. Agaeva, G. Shelkova, 2020, Terapevticheskii arkhiv.

First results of Russian multicenter prospective clinical study VICTORY II: Vamloset® and Co-Vamloset effectiveness and safety in patients with stage 2 and 3 arterial hypertension

Yu. I. Grinshtein, O. Rotar, I. Chazova, 2020 .

Possibilities of blood pressure and metabolic disorders correction by using diet programs in patients with overweight and obesity

I. Chazova, J. V. Zhernakova, N. Blinova, 2019, Systemic Hypertension.

Guidelines for diagnostics and treatment of hypertension 2018 - European experts’opinion [Guidelines]

I. Chazova, Y. Zhernakova, 2018, Systemic Hypertension.

["Guiding lights" for the diagnosis of chronic thromboembolic pulmonary hypertension in the flow of patients with pulmonary embolism].

I. Chazova, T. Martynyuk, A. A. Shmalts, 2022, Terapevticheskii arkhiv.

Pulmonary hypertension in a patient with kyphoscoliotic heart disease

I. Chazova, O. Sagaydak, N. Danilov, 2019, The Siberian Medical Journal.

Radiofrequency denervation of renal arteries. Myth or reality

I. Chazova, Y. Matchin, N. Danilov, 2015 .

[Comparative capabilities of the speckle-tracking echocardiography technologiesin two-dimensional and three-dimensional modes in the detection of subclinical cardiotoxicity in patients with breast cancer].

E. Oshchepkova, I. Chazova, M. Saidova, 2020, Terapevticheskii arkhiv.

Long-term outcomes after percutaneous transluminal pulmonary angioplasty for chronic thromboembolic pulmonary hypertension

I. Chazova, Y. Matchin, N. Danilov, 2019 .

Right heart remodeling in patients with inoperable chronic thromboembolic pulmonary hypertension after balloon angioplasty of the pulmonary arteries

I. Chazova, O. Sagaydak, M. Saidova, 2019 .

Angiotensin II receptor antagonists – we have moved closer to the patient

I. Chazova, Г. Ратова, L. G. Ratova, 2018 .

Family hyperaldosteronism type I: a clinical case and review of literature.

I. Chazova, O. Favorova, N. Chikladze, 2018, Terapevticheskii arkhiv.

[Heart failure and obesity].

S. Tereshchenko, I. Chazova, A. Safiullina, 2022, Terapevticheskii arkhiv.

[Pulmonary hypertension in Russia: the first results of the national register].

I. Chazova, Z. Valieva, S. Nakonechnikov, 2014, Terapevticheskii arkhiv.

Pulmonary arterial hypertension in Russia: six-year observation analysis of the National Registry.

I. Chazova, T. Martynyuk, O. Arkhipova, 2019, Terapevticheskii arkhiv.

Prevention of Cardioembolic Complications in Patients with Atrial Fibrillation: Efficacy and Safety of Left Atrial Appendage Isolation and Oral Anticoagulants

A. K. Alieva, I. Chazova, E. Merkulov, 2022, Rational Pharmacotherapy in Cardiology.

Oxidative and carbonyl stress as a factors of the modification of proteins and DNA destruction in diabetes

I. Chazova, V. Lankin, G. Konovalova, 2018, Terapevticheskii arkhiv.

Oxidative and carbonyl stress as a factors of the modification of proteins and DNA destruction in diabetes.

I. Chazova, V. Lankin, G. Konovalova, 2018, Terapevticheskii arkhiv.

Experience with various occluder types for endovascular hemodynamic isolation of the left atrium appendage in patients with non-valvular atrial fibrillation

I. Chazova, A. Ushanova, E. Merkulov, 2021, Journal of Arrhythmology.

[Influence of demographic characteristics on the clinical course and results of therapy in patients with precapillary pulmonary hypertension].

I. Chazova, M. Saidova, T. Martynyuk, 2021, Terapevticheskii arkhiv.

Russian Medical Society for Arterial Hypertension Expert Consensus: Hypertension and COVID-19

S. Boytsov, E. Oshchepkova, I. Chazova, 2020 .

Consensus of experts from the Russian Medical Society of Arterial Hypertension. Arterial hypertension and erectile dysfunction

I. Chazova, V. Podzolkov, V. Larina, 2021, Systemic Hypertension.

Arterial hypertension in the light of current recommendations.

I. Chazova, 2018, Terapevticheskii arkhiv.

Comparative evaluation new glucagon-like peptide 1 receptor agonist semaglutide and sodium-glucose cotransporter-2 inhibitors empagliflozin on left ventricular diastolic function in patients with arterial hypertension, obesity and type 2 diabetes mellitus

I. Chazova, Y. Zhernakova, M. Saidova, 2022, Systemic Hypertension.

Pulmonary hypertension: current issues of diagnosis and treatment

I. Chazova, S. Nakonechnikov, T. Martyniuk, 2011, Eurasian heart journal.

Clinical features and course of arterial hypertension in patients with its various forms

I. Chazova, O. Sivakova, T. D. Solntseva, 2021, Systemic Hypertension.

[Treatment of patients with arterial hypertension in clinical practice in 2010-2020 (according to the national register of hypertension)].

I. Chazova, E. Oschepkova, A. Aksenova, 2022, Terapevticheskii arkhiv.

The clinical case of successful combined treatment of refractory arterial hypertension. Case report

I. Chazova, N. Danilov, O. Sivakova, 2021, Terapevticheskii arkhiv.

Results of a Russian multicenter open prospective study of the efficacy and safety of Telmista® and Telmista® H in patients with arterial hypertension 1 and 2 degrees

O. Y. Trifonova, S. I. Kseneva, I. Chazova, 2022, Systemic Hypertension.

[The assessment of renal function during the therapy of arterial hypertension with azilsartan medoxomil in patients with obesity or overweight and concomitant metabolic disorders].

I. Chazova, J. V. Zhernakova, V. Nevzorova, 2021, Terapevticheskii arkhiv.

Uncontrolled hypertension and obstructive sleep apnea: integrated treatment approach

I. Chazova, O. Mikhailova, A. Litvin, 2022, Systemic Hypertension.

Comparison of vectorcardiographic parameters with structural-functional state of the right ventricle in patients with pulmonary hypertension

I. Chazova, E. Aidu, V. Trunov, 2015 .

Possibilities of electrocardiographic and decartographic parametersin the diagnosis of right ventricular overload in patients with pulmonary arterial hypertension

I. Chazova, V. Trunov, E. Blinova, 2015 .

[A clinical case of long-term macitentan therapy in a female patient with idiopathic pulmonary hypertension].

I. Chazova, T. Martynyuk, O. Arkhipova, 2016, Terapevticheskii arkhiv.

Radioligand method of assessment of human T-lymphocytes’ β-adrenoceptors activity

I. Chazova, Y. Skoblov, O. Agapova, 2015, Russian Journal of Bioorganic Chemistry.

Pulmonary arterial hypertension: challenges and achievements 2021

I. Chazova, T. Martynyuk, Z. Valieva, 2022, Eurasian heart journal.

[The effect of long-term Fraxiparin treatment on hemostasis in patients with primary pulmonary hypertension].

I. Chazova, E. Titaeva, A. B. Dobrovol'skii, 1997, Terapevticheskii arkhiv.

Arterial hypertension in adults. Clinical guidelines 2020

S. Shalnova, R. Libis, O. Drapkina, 2020, Russian Journal of Cardiology.

Arterial stiffness and vascular aging in relation to coalugogical CVD risk factors, parameters of lipid and carbohydrate metabolism in adult population of Tomsk in the framework of the project ESSE-RF

I. Trubacheva, I. Chazova, A. Dobrovolsky, 2018 .

[From palpation of the pulse to cuff-free methods: evolution of arterial pressure measurement methods].

I. Chazova, O. Sivakova, T. D. Solnceva, 2021, Terapevticheskii arkhiv.

Eurasian clinical guidelines for cardiovascular complications of cancer treatments: diagnosis, prevention and treatment (2022)

F. Ageev, I. Chazova, M. Gilyarov, 2022, Eurasian heart journal.

Multiple rare and common variants in APOB gene locus associated with oxidatively modified low-density lipoprotein levels

S. Boytsov, E. Yarovaya, I. Chazova, 2019, PloS one.

Management of patients with arterial hypertension and atrial fibrillation

I. Chazova, J. V. Zhernakova, E. Zheleznova, 2021, Systemic Hypertension.

Uncontrolled arterial hypertension in patients with breast cancer and the risk of developing cardiotoxicity with anthracycline-containing chemotherapy

E. Oshchepkova, I. Chazova, M. Saidova, 2019 .

Effect of chemotherapy on the length of telomeres in patients with breast cancer suffering from arterial hypertension

F. Ageev, E. Oshchepkova, I. Chazova, 2018 .

The problem of broncho-obstructive syndrome early detection in cardiological patients. Review of specialized respiratory questionnaires and their use in patients with comorbid cardiovascular and broncho-obstructive pathologies

I. Chazova, Чазова Ирина Евгеньевна, K. Zykov, 2018 .

Comparison of single-pill strategies first line in hypertension: perindopril/amlodipine versus valsartan/amlodipine

G. Mancia, R. Asmar, S. Taddei, 2015, Journal of hypertension.

[Cardiovascular and chronic obstructive pulmonary diseases: pathophysiological processes and treatment tactics].

I. Chazova, L. Ambatiello, 2020, Terapevticheskii arkhiv.

2020 Clinical practice guidelines for Pulmonary hypertension, including chronic thromboembolic pulmonary hypertension

O. Barbarash, I. Chazova, O. Stukalova, 2021, Russian Journal of Cardiology.

Arterial hypertension and chronic obstructive pulmonary disease: clinical characteristics and treatment efficasy (according to the national register of arterial hypertension).

E. Oshchepkova, N. Lazareva, I. Chazova, 2019, Terapevticheskii arkhiv.

The role of beta-blockers in the treatment of arterial hypertension: what do we know today

I. Chazova, Y. Zhernakova, Жернакова Юлия Валерьевна, 2015 .

[Sleep disorders and stroke: data of the esse-rf study].

S. Shalnova, A. Konradi, O. Rotar, 2019, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova.

Antihypertensives and Statin Therapy for Primary Stroke Prevention: A Secondary Analysis of the HOPE-3 Trial

S. Yusuf, J. Bosch, G. Dagenais, 2021, Stroke.

[Pulmonary arterial hypertension: achievements and realities of modern treatment, a look into the future].

I. Chazova, T. Martynyuk, 2021, Terapevticheskii arkhiv.

Obstructive sleep apnea syndrome and arterial hypertension: bidirectional relationship

I. Chazova, O. Mikhailova, A. Litvin, 2015 .

Randomized evaluation of a novel, fixed-dose combination of perindopril 3.5 mg/amlodipine 2.5 mg as a first-step treatment in hypertension

G. Parati, S. Laurent, A. Erglis, 2015, Journal of hypertension.

The influence of systemic and ectopic fat depots on the state of kidney function

I. Chazova, Y. Zhernakova, M. Azimova, 2023, Systemic Hypertension.

EURASIAN ASSOCIATION OF CARDIOLOGY (EAC) GUIDELINES FOR THE PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASES IN PATIENTS WITH DIABETES AND PREDIABETES (2021)

M. Shestakova, I. Zhirov, I. Chazova, 2021, Eurasian heart journal.

Overweight and Obesity in the Russian Population: Prevalence in Adults and Association with Socioeconomic Parameters and Cardiovascular Risk Factors

J. Breda, A. Deev, S. Shalnova, 2019, Obesity Facts.

Gender characteristics of obstructive sleep apnea syndrome clinical manifestations and patients' quality of life

I. Chazova, Чазова Ирина Евгеньевна, Литвин Александр Юрьевич, 2019, Systemic Hypertension.

Control of cardiovascular risk in patients with diabetes

I. Chazova, Y. Zhernakova, 2016 .

[Russian Medical Society for Arterial Hypertension expert consensus. Resistant hypertension: detection and management].

E. Oshchepkova, I. Chazova, O. Kisliak, 2021, Terapevticheskii arkhiv.

EURASIAN ASSOCIATION OF CARDIOLOGY (EAC)/ RUSSIAN NATIONAL ATHEROSCLEROSIS SOCIETY (RNAS, RUSSIA) GUIDELINES FOR THE DIAGNOSIS AND CORRECTION OF DYSLIPIDEMIA FOR THE PREVENTION AND TREATMENT OF ATHEROSCLEROSIS (2020)

S. Boytsov, D. Duplyakov, O. Drapkina, 2020 .

STRUCTURAL CHANGES OF THE PULMONARY ARTERIES AFTER BALLOON PULMONARY ANGIOPLASTY IN PATIENTS WITH CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION

I. Chazova, N. Danilov, Y. Matchin, 2020 .

Arterial hypertension and chronic kidney disease: consensus statement on patient management

I. Chazova, O. Mironova, V. Fomin, 2023, Systemic Hypertension.

Metabolically healthy obese and metabolically unhealthy non-obese phenotypes in a Russian population

A. Deev, S. Shalnova, S. Boytsov, 2017, European Journal of Epidemiology.

[Comorbidity of cardiovascular diseases and cancers: Problems in the diagnosis of cardiotoxic effects of chemo- and radiation therapy].

E. Oshchepkova, I. Chazova, A. Kantorová, 2015, Terapevticheskii arkhiv.

Assessment of the prevalence of target organ damage at various stages of the cardiometabolic continuum. According to the ESSE RF study

E. Yarovaya, I. Trubacheva, E. Oshchepkova, 2022, Systemic Hypertension.

Eurasian clinical guidelines for the diagnosis and treatment of secondary (symptomatic) forms of arterial hypertension (2022)

Z. Belaya, I. Chazova, N. Blinova, 2023, Eurasian heart journal.

Clinical and radiological aspects of reperfusion pulmonary edema after balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension

I. Chazova, O. Mikhailova, N. Danilov, 2022, Systemic Hypertension.

Hybrid approach for treating patient with chronic thromboembolic pulmonary hypertension and extrinsic compression of left main coronary artery

I. Chazova, O. Sagaydak, Y. Matchin, 2019 .

Electrocardiographic Predictors of Response to Vasoreactivity Testing in Patients with Pulmonary Arterial Hypertension

I. Chazova, E. Aidu, V. Trunov, 2014 .

Cardioncology: management of arterial hypertension in patients with cancer on chemotherapy

I. Chazova, E. Oschepkova, M. Kirillova, 2015 .

Analysis of lifestyle modifications and antihypertensive therapy in patients with arterial hypertension and chronic kidney disease (data from the national registry)

E. Oshchepkova, I. Chazova, A. Orlovsky, 2022, Systemic Hypertension.

COMPLAINTS ON SLEEP BREATHING DISORDER AND CARDIOVASCULAR RISK FACTORS IN RUSSIAN REGIONS: DATA FROM ESSE-RF STUDY

S. Shalnova, S. Boytsov, L. Korostovtseva, 2018, Russian Journal of Cardiology.

The economic burden of chronic thromboembolic pulmonary hypertension in Russian Federation.

I. Chazova, S. Nedogoda, T. Martynyuk, 2018, Terapevticheskii arkhiv.

State of the art for diagnosis and treatment of orthostatic hypotension

I. Chazova, A. Rogoza, S. Gorieva, 2018, Systemic Hypertension.

Russian medical society expert consensus on arterial hypertension: arterial hypertension and Post-COVID syndrome

E. Oshchepkova, I. Chazova, J. V. Zhernakova, 2022, Systemic Hypertension.

ARTERIAL HYPERTENSION AMONG INDIVIDUALS OF 25–64 YEARS OLD: PREVALENCE, AWARENESS, TREATMENT AND CONTROL. BY THE DATA FROM ECCD

N. I. Babenko, A. Deev, S. Shalnova, 2014 .

The effectiveness of combination antihypertensive therapy in patients with arterial hypertension and additional risk factors: obesity and obstructive sleep apnea syndrome.

I. Chazova, E. Elfimova, A. Litvin, 2018, Terapevticheskii arkhiv.

Features of the manifestation of arterial hypertension in patients with a new coronavirus infection

I. Chazova, O. Sivakova, T. D. Solnceva, 2022, Eurasian heart journal.

THE EFFECTIVENESS OF THERAPY PERINDOPRIL ARGININE IN TREATMENT OF PATIENTS WITH HYPERTENSION AND DIABETES TYPE 2 IN NATIONAL PROGRAM “PREMIA”: PP.11.294

I. Chazova, Masenko Vp, S. Olimpieva, 2011 .

The prevalence of diabetes mellitus in population of hypertensive patients according to ESSE RF study results

S. Shalnova, E. Yarovaya, A. Konradi, 2018 .

[Prevalence of cardiiovascular risk factors in Russian population of patients with arterial hypertension].

A. Konradi, E. Oshchepkova, I. Chazova, 2014, Kardiologiia.

Changes in the receptor activity of β2-adrenoreceptors of human T-lymphocytes under the effect of β2-agonists

I. Chazova, N. Mironova, S. Golitsyn, 2016, Molecular Biology.

[Obstructive sleep apnea syndrome and cardiovascular risk factors in the antihypertensive therapy "escape" phenomenon].

I. Chazova, O. Mikhailova, A. Litvin, 2023, Terapevticheskii arkhiv.

[COVID-19 and cardiovascular diseases].

I. Chazova, O. Mironova, 2020, Terapevticheskii arkhiv.

Effects of the lercanidipine–enalapril combination vs. the corresponding monotherapies on home blood pressure in hypertension: evidence from a large database

G. Parati, G. Mancia, Stefano Omboni, 2016, Journal of hypertension.

Continuous positive airway pressure therapy and carbohydrate and lipid metabolism in patients with Z syndrome

I. Chazova, A. Litvin, A. Litvin, 2008 .

Moxonidine improves glycaemic control in mildly hypertensive, overweight patients: a comparison with metformin

Evgeny Shlyakhto, V. A. Almazov, E. Shlyakhto, 2006, Diabetes, obesity & metabolism.

[Activity of renin-angiotensin-aldosterone system (RAAS) and vasopressin level in patients with primary pulmonary hypertension].

V. N. Volkov, I. Chazova, I. Belenkov, 1998, Terapevticheskii arkhiv.

Disorders of lipid metabolism. Clinical Guidelines 2023

D. Duplyakov, O. Rotar, M. Shestakova, 2023, Russian Journal of Cardiology.

Single pill combinations present a proven fast track in practice to reach the target blood pressure

B. Jelaković, I. Chazova, J. Brguljan, 2021, European Heart Journal.

Obstructive sleep apnea syndrome

I. Chazova, Irina Chazova, Чазова Ирина Евгеньевна, 2009 .

DIAGNOSTICS AND TREATMENT OF ARTERIAL HYPERTENSION

I. Chazova, Y. Zhernakova, E. V. Oshepkova, 2015, Eurasian heart journal.

COVID-19: a patient with cardiovascular disease at high risk

I. Chazova, O. Ostroumova, Y. Zhernakova, 2020 .

Advantages azilsartan medoxomil in patients with arterial hypertension: how to make a choice and to optimize antihypertensive therapy?

I. Chazova, T. Martynyuk, 2017 .

Consensus on renovascular hypertension: diagnosis and treatment

I. Bobkova, I. Chazova, O. Mironova, 2023, Systemic Hypertension.

[Direct human DNA damage by unfavorable environmental and climatic factors].

I. Chazova, N. Konovalova, O. Rodnenkov, 2014, Terapevticheskii arkhiv.

[Telomere length as a biomarker of the risk of cardiovascular complications in patients with coronary heart disease].

M. Smirnova, I. Chazova, V. Lankin, 2021, Terapevticheskii arkhiv.

Влияние терапии постоянным положительным давлением на показатели углеводного и липидного обменов у больных с синдромом Z Continuous positive airway pressure therapy and carbohydrate and lipid metabolism in patients with Z syndrome

I. Chazova, A. Litvin, A. Litvin, 2018 .

Management of acute coronary syndrome in older adults (data from russian federal acute coronary syndrome registry).

I. Chazova, O. Sagaydak, E V Ocshepkova, 2018, Terapevticheskii arkhiv.

Clinical and diagnostic features of uncontrolled hypertension and including hypertensive crisis

I. Chazova, O. Sivakova, T. D. Solntseva, 2023, Systemic Hypertension.

A pilot study to determine the relationship of changes in the characteristics of β1- and β2-adrenoreceptors against the background of the use of β2-agonists with clinically significant parameters in patients with cardiovascular pathology

I. Chazova, Y. Skoblov, A. Eremenko, 2023, Journal of Clinical Practice.

THE EFFECT OF SELECTIVE BETA1-ADRENOBLOCKER ON THE CHARACTERISTICS OF BETA2-ADRENORECEPTORS IN PATIENTS WITH CARDIORESPIRATORY PATHOLOGY

I. Chazova, Y. Skoblov, K. Zykov, 2019, Journal of Hypertension.

PCSK9 Inhibitor causes a decrease in the level of oxidatively modified low-density lipoproteins in patients with coronary artery diseases.

M. Viigimaa, I. Chazova, V. Lankin, 2018, Terapevticheskii arkhiv.

Surgical Treatment of Congenital Heart Diseases Associated with Pulmonary Hypertension in Adults

I. Chazova, T. Martynyuk, S. Gorbachevsky, 2023, Annals of the Russian academy of medical sciences.

[Treatment of patients with long nocturnal asystoles and obstructive sleep apnea syndrome by creating continuous positive air pressure in the upper respiratory tract].

I. Chazova, S. Golitsyn, A. Pevzner, 2009, Kardiologiia.

[Possibilities of using levosimendan in patients with idiopathic pulmonary hypertension].

I. Chazova, N. Danilov, T. Martyniuk, 2012, Terapevticheskii arkhiv.

The frequency of detection of comorbid broncho-obstructive pathology in patients with arterial hypertension admitted to a specialized cardiological hospital

I. Chazova, K. Zykov, A. Klimova, 2023, Systemic Hypertension.

Effects on office and home blood pressure of the lercanidipine-enalapril combination in patients with Stage 2 hypertension: a European randomized, controlled clinical trial

G. Mancia, H. Haller, D. Pupek-Musialik, 2014, Journal of hypertension.

Sleep duration and cardiovascular risk: results of the large-scale epidemiology study ESSE-RF

S. Shalnova, S. Boytsov, A. Konradi, 2019 .

2024 Clinical practice guidelines for Hypertension in adults

R. Libis, I. Chazova, Y. Lopatin, 2024, Russian Journal of Cardiology.